pharma
Philip Hampton to step down from chairman role at GSK
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
Novartis warns of huge impact of no-deal Brexit
January 28, 2019Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma
Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
Head of opioid advisory panel criticises FDA for complacency in ongoing crisis
January 28, 2019Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma
The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …
Top Ten most popular articles on Pharmafile.com this week!
January 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo
While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …
China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk
January 25, 2019Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke
Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …
NHS App begins public rollout across England following successful testing
January 24, 2019Medical Communications England, NHS, NHS App, UK, health, pharma
NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …
EMA rejects Lilly’s Lartruvo in soft tissue cancer following trial failure
January 24, 2019Sales and Marketing Cancer, EMA, Eli Lilly, Lartruvo, pharma
Eli Lilly has been dealt a blow as the European Medicines Agency announced its recommendation for soft tissue cancer patients …
Amgen’s Blincyto secures expanded indication in Europe for acute lymphoblastic leukaemia
January 23, 2019Research and Development, Sales and Marketing Ammgen, Cancer, Europe, European Commission, blincyto, leukaemia, pharma
The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, …
Including prices on TV ads only works when the price is listed alone
January 23, 2019Research and Development Trump, USA, pharma, pricing
Requiring pharmaceutical companies to publish the price of their drugs on adverts on TV, would probably not help to control …
FDA approves third Herceptin biosimilar with Samsung Bioepis’ Ontruzant
January 22, 2019Manufacturing and Production, Sales and Marketing FDA, Herceptin, Samsung Bioepis, biosimilar, pharma
Samsung Bioepis’ has announced that the FDA has chosen to approve Ontruzant (trastuzumab-dttb), its biosimilar version of Roche’s Herceptin (trastuzumab), …
Boehringer expands manufacturing facility in Shanghai
January 22, 2019Manufacturing and Production Boehringer Ingelheim, China, Shanghai, facilities, manufacturing, pharma
German firm Boehringer Ingelheim has expanded the capacity of its commercial manufacturing site for biologics in Shanghai, China. The expansion …
Vertex’s Orkambi can be used in even younger cystic fibrosis patients, says European Commission
January 22, 2019Manufacturing and Production, Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma
Vertex has announced that the European Commission has decided to approve a label extension in the region for Orkambi (lumacaftor/ivacaftor) …
Pushing for progress in mesothelioma
January 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, mesothelioma, pharma
Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …
Lilly’s Lartruvo/chemo combo surprises with Phase 3 failure in soft tissue carcinoma
January 21, 2019Research and Development, Sales and Marketing Cancer, Eli Lilly, carcinoma, chemotherapy, pharma, trial failure
Eli Lilly has reluctantly pulled back the curtain on new Phase 3 data for its platelet-derived growth factor receptor alpha …
NICE recommends Pierre Fabre’s Braftovi in BRAF V600-mutated advanced melanoma
January 21, 2019Sales and Marketing Braftovi, Cancer, NICE, Pierre Fabre, UK, melanoma, pharma
Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval in combination with Mektovi (binimetinib) by …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
